TNDM - Bragar Eagel & Squire P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath Tandem and Leslie's and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UiPath, Inc. (NYSE:PATH), Tandem Diabetes Care, Inc. (NASDAQ:TNDM), and Leslie's, Inc. (NASDAQ:LESL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
UiPath, Inc. (NYSE:PATH)
Class Period: April 21, 2021 - March 30, 2022 (Common Stock Only)
Lead Plaintiff Deadline: November 6, 2023
On September 7, 2021, UiPath released its second quarter 2022 financial results, revealing a slowdown in the Company's revenues and reported annualized renewal run-rate ("ARR"). The Company also revealed that its financial results provided to investors in connection with the Company's Initial Public Offering had been boosted by previously undisclosed discounting, and that UiPath was shifting away from discounted multi-year contract and moving to a "ramping" contact model. On this news, UiPath's stock price fell $8.06, or 12.9%, to close at $54.40 per share on September 9, 2021, thereby injuring investors.
Then, on March 30, 2022, UiPath released disappointing revenue and ARR guidance for its fiscal year 2023, stating that the downward growth trajectory was expected to continue. On this news, UiPath's stock price fell $7.45, or 25.7%, to close at $21.59 per share on March 31, 2022, thereby injuring investors further.
For more information on the UiPath class action go to: ...